EU pharmaceuticals

What are EU pharmaceuticals

EU pharmaceuticals are original branded medicines from international pharmaceutical companies that are purchased cheaply from other countries in Europe and imported. In terms of effectiveness and quality, they are completely identical to the original preparations and are also subject to all of the laws and standards of German medicines legislation. The lower prices come about through the difference in market prices between other EU countries and Germany. Essentially, there are two forms of import: re-imports and parallel imports.

You will find further information on imported pharmaceuticals at www.die-arzneimittel-importeure.de

 

EU pharmaceuticals as re-imports

Re-imports are branded preparations that are produced by a pharmaceutical company in Germany and exported to an EU country. We purchase these medicines from a pharmaceutical wholesaler in an EU country and import them back to Germany.

EU pharmaceuticals as parallel imports

Parallel imports are also branded preparations from multi-national pharmaceutical companies. They are originally manufactured in another EU country and then imported into Germany.
 

Our comprehensive array of EU pharmaceuticals

The portfolio of EU pharmaceuticals products at axicorp is made up primarily of prescription-only medicines and comprises over 1,600 PZNs (pharmaceutical central numbers). Our broad and demand-focused selection covers a range of indications. These include neurology and multiple sclerosis, diabetes, oncology, rheumatology, HIV, allergy, dermatology, gynaecology and vaccines, to name but a few.

An up-to-date product list can be found in our portfolio summary. 

To the service portal with a summary of our portfolio

 

You are not logged in